Rewind Therapeutics

Foundation date

27/09/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

We discover and develop innovative first-in-class remyelinating therapies for patients suffering from multiple sclerosis and other myelin-related diseases.

Upcoming events

Latest news

  • Mithra appoints experienced life sciences executive Christian Homsy* as Chairman

    1 day ago

  • Oxurion reaches enrollment target in KALAHARI Phase 2, Part B trial of novel PKal inhibitor THR-149 in diabetic macular edema

    Friday May 26th 2023

  • How garbage disposal clogs in cells can lead to Alzheimer’s

    Friday May 26th 2023